Probiota Asia 2018

WATCH — 'A daunting task': IPA chief on the challenges of commercialising a global probiotic product

This content item was originally published on www.nutraingredients-asia.com, a William Reed online publication.

06-Nov-2018 - Last updated on 28-Sep-2021 at 12:51 GMT

Companies seeking to commercialise a probiotic product across the globe face a 'daunting task', which is why trade association the International Probitics Association (IPA) is vowing not to let up in its efforts to achieve a more consistent global regulatory regime.

NutraIngredients, in conjunction with GOED, will be holding APAC's first ever omega-3 event in Singapore in February 2019, featuring renowned speakers from CSIRO, A*STAR, Koure, GOED and more.

Find out how to attend.

The organisation's executive director George Paraskevakos was a keynote speaker at our Probiota Asia summit in Singapore, where he gave an overview of the current rules across the globe.

"It's incredibly difficult," he said. "Even if you take a look at the permitted lists of strains, there is huge variation."

We spoke with Paraskevakos after his presentation, where he provided an update on the organisation's efforts to usher in a more harmonised regime through CODEX, and revealed some recent advances in the US rules.

He also discusses the current market performance of probiotics across Asia Pacific, and the booming China sector in particular.